EXCLUSIVE: PainReform's Non-Opiate Post-Surgical Pain Relief Treatment Outperforms Rival Medicine Under Various Testing Conditions [Yahoo! Finance]
PainReform Ltd. - Ordinary Shares (PRFX)
Company Research
Source: Yahoo! Finance
These findings underscore PainReform's commitment to advancing non-opiate pain relief options and mark a significant milestone in developing long-lasting pain management solutions. Leveraging the latest IVR technology, which automates the testing of drug release from formulations over time, PainReform conducted comprehensive studies to evaluate the performance of PRF-110. Over a 72-hour industry-standard duration and extending to 96 hours, PRF-110 exhibited higher rates of analgesic drug release compared to a market-leading post-surgical pain product. Results indicated that PRF-110 released between 34%-77% more drug over 96 hours under various testing conditions. The results support PRF-110's superior efficacy and its potential to extend the pain relief duration significantly. By ensuring a more consistent and prolonged analgesic effect, PRF-110 aims to reduce the dependency on opiates for post-surgical pain management, the company said. Last week, PainReform announced it
Show less
Read more
Impact Snapshot
Event Time:
PRFX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRFX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRFX alerts
High impacting PainReform Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
PRFX
News
- PainReform Announces Closing of $4 Million Public Offering [Yahoo! Finance]Yahoo! Finance
- PainReform Announces Closing of $4 Million Public OfferingGlobeNewswire
- PainReform Announces Pricing of $4 Million Public Offering [Yahoo! Finance]Yahoo! Finance
- PainReform Announces Pricing of $4 Million Public OfferingGlobeNewswire
- PainReform’s Non-Opiate Topical Treatment for Post-Surgical Pain Relief Outperforms Leading Competitor Under Various Testing ConditionsGlobeNewswire
PRFX
Sec Filings
- 4/24/24 - Form SC
- 4/17/24 - Form 6-K
- 4/17/24 - Form 424B3
- PRFX's page on the SEC website